The largest purchase of all time was on 2018-09-07 and amounted to 30000000 shares of Adaptimmune Therapeutics plc for $50M.
The largest sale of all time was on 2017-11-20 and amounted to 5641032 shares of Appian Corporation for $109.94M.
No biography is available at this moment.
| 2018-09-07 | Adaptimmune Therapeutics plc ADAP | 10 percent owner | 30M 4.8721% | $1.67 | $50M | -57.66% | ||
| 2018-03-27 | Adaptimmune Therapeutics plc ADAP | 10 percent owner | 12M 2.1988% | $1.92 | $23M | -12.28% | ||
| 2018-03-26 | Adaptimmune Therapeutics plc ADAP | 10 percent owner | 1.14M 0.2007% | $1.90 | $2.18M | -14.01% | ||
| 2018-03-23 | Adaptimmune Therapeutics plc ADAP | 10 percent owner | 588,180 0.1062% | $1.95 | $1.14M | -12.52% | ||
| 2018-03-22 | Adaptimmune Therapeutics plc ADAP | 10 percent owner | 1.74M 0.308% | $1.90 | $3.31M | -12.12% | ||
| 2018-03-21 | Adaptimmune Therapeutics plc ADAP | 10 percent owner | 209,688 0.0355% | $1.81 | $379,640 | -10.61% | ||
| 2017-11-27 | Sale | Appian Corporation APPN | 10 percent owner | 1.14M 2.1156% | $19.49 | $22.2M | +42.78% | |
| 2017-11-20 | Sale | Appian Corporation APPN | 10 percent owner | 5.64M 11.2735% | $19.49 | $109.94M | +53.66% | |
| 2017-10-10 | Rhythm Pharmaceuticals, Inc. RYTM | 10 percent owner | 550,000 1.3734% | $17.00 | $9.35M | +9.57% | ||
| 2017-07-03 | Mersana Therapeutics, Inc. MRSN | 10 percent owner | 2M 9.7597% | $15.00 | $30M | +20.77% | ||
| 2017-03-27 | Adaptimmune Therapeutics plc ADAP | 10 percent owner | 25.74M 5.5147% | $0.70 | $18.02M | +55.36% | ||
| 2016-07-18 | Ardelyx, Inc. ARDX | 10 percent owner | 3.05M 5.9523% | $8.73 | $26.67M | +25.38% | ||
| 2016-01-13 | Ardelyx, Inc. ARDX | 10 percent owner | 1M 3.0335% | $10.00 | $10M | +4.47% | ||
| 2015-10-06 | Synlogic, Inc. SYBX | 10 percent owner | 857,142 4.1031% | $7.00 | $6M | -36.97% | ||
| 2014-10-08 | Journey Medical Corporation DERM | 10 percent owner | 69,112 0.9158% | $16.00 | $1.11M |